Compensatory Pathways Induced by MEK Inhibition Are Effective Drug Targets for Combination Therapy Against Castration-Resistant Prostate Cancer
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-10-1033
Full Text
Open PDFAbstract
Available in full text
Date
June 28, 2011
Authors
Publisher
American Association for Cancer Research (AACR)